0      0


Short Talk: Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8+ T Cells


Aug 17, 2020 5:55pm ‐ Aug 17, 2020 6:10pm



Credits: None available.

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.